🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our wonderful participants from the 3rd Immuno-Metabolic Mechanisms of Atherosclerosis conference that took place in Mexico last month, hope to see you all again at the next edition!☀️🇲🇽 #IMMA22

The status of #fattyliverdisease can be identified by a subtype of #macrophages that have a protective function against #fibrosis and #livercirrhosis. Details of the study from a #MedUniVienna research team are available in Journal of Hepatology. ⬇️ bit.ly/3n6J3oK

Excited to see some of the work I did during my PhD published in Journal of Hepatology today! Great team effort with Tim Hendrikx, Christoph Binder lab and our collaborators! Check it out doi.org/10.1016/j.jhep…

I had the pleasure of defending my PhD yesterday after exciting years at MedUni Wien CeMM! Huge thank you to all the incredible people that supported me and accompanied me on this journey - thank you particularly to my mentor Christoph Binder! Now on to new adventures😎

It was a great pleasure to chair the Young Fellows session EAS Congress together with @vanderVorstLab and some great talks by Esther Lutgens Tian Zhao Marie Depuydt Anton Gisterå Sanne Maas Ottavia Terenghi T. Koller

Such a great week of Science at Gordon Research Conferences in Spain enjoying athero discussions and creating new collaborations and ideas under the sunshine! Florentina Porsch Christoph Binder Fil Swirski & Scientists Kathryn Moore Lab

Very happy to have contributed to this work further unravelling the role of complement in atherosclerosis!

Come join our team in beautiful Vienna!

Very happy to see our work on TREM2 in MAFLD recognised with the Helmut Sinzinger Prize of the College of Physicians in Vienna Gesellschaft der Ärzte in Wien - Billrothhaus Congratulations Tim Hendrikx !

Excited to see our work shedding further light on the pivotal role of TREM2 in atherosclerosis and the potential of targeting TREM2 therapeutically out in Nature Cardiovascular Research today! Thank you to all our collaborators!

Congratulations to Mate Kiss for being awarded the Young Investigator Award of the European Atherosclerosis Society for his work elucidating the role of complement factor H in atherosclerosis, published in Immunity! doi.org/10.1016/j.immu…

🎓PhD Opportunity! Our lab at MedUni Vienna is now accepting applications for PhD candidates. labormedizin.meduniwien.ac.at/en/research/re… Apply online by 15.04.2024, 23:55CET at bit.ly/3l7WMhs. #PhDOpportunity #Research #PhDLife #cardiovascular #atherosclerosis #extracellularvesicles

Mate Kiss receiving the Young Investigator Award of the European Atherosclerosis Society for his publication on the role of complement factor H in atherosclerosis published in Immunity Congratulations!!🎉#EAS #EASCongress2024 #MyEAS

Thrilled to share our latest review exploring the interface between autoimmunity and atherosclerosis out in Nature Reviews Cardiology today! Christoph Binder MedUni Wien rdcu.be/dL4VC

Check out our latest review on the role of antibodies in atherosclerosis!

Happy to share our new paper on extracellular vesicles triggering NETosis in myocardial infarction and the protective effect of natural IgM in this process, published simultaneously with the #ESCCongress in the #EHJ European Society of Cardiology Journals doi.org/10.1093/eurhea…

Our review on management of CVD in immune-mediated diseases. A great team work brilliantly coordinated by Maya Buch. Marc Dweck Jason Tarkin Declan O'Regan Vanessa Ferreira Taryn Youngstein Sven Plein #CARDIO-IMID UK Network Medical Research Council British Heart Foundation eur03.safelinks.protection.outlook.com/?url=https%3A%…

Excited to share Episode 8 of #AtheroTalk! I had the pleasure of interviewing my inspiring colleague and friend, Dr. Máté Kiss, recipient of the 2024 European Atherosclerosis Society Young Investigator Award, on his award-winning work in Immunity and beyond! MedUni Wien doi.org/10.1016/j.immu…

‼️To all early-career researchers👩🏻‍💻👨🏼‍🔬: The EAS Congress is just around the corner. Tune into our latest #AtheroTalk episode to get familiar with leading researchers before you meet them in person. Give it a listen and let us know what you think! Spotify: open.spotify.com/episode/3oylsP…

Research| Case et al. report that low-dose interleukin-2 clonally expands Tregs and maintains their suppressive program by bypassing BACH2 downregulation in patients with acute coronary syndrome from the LILACS trial.Mallat_Lab Tian Zhao Ziad Mallat rdcu.be/ephaW